| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |